Representatives of the NMRC for Hematology of the Ministry of Health of the Russian Federation, Candidate of Medical Sciences, H.L. Julhakyan; Candidate of Medical Sciences, L. G. Gorenkova; and Candidate of Medical Sciences, E.S. Nesterova took part in the XII annual meeting of the Society of Hematological Oncology (SOHO 2024) organized by MDAnderson. This landmark event for hematology took place from 4-7 September, 2024 at the George R. Brown Convention Center in Houston, Texas. The event was attended by almost 3,800 hematological oncology specialists from all over the world, providing participants with an opportunity to communicate face-to-face with world-class scientists and gain knowledge about the latest achievements in hematology.
The following poster presentations of the NMRC for Hematology were exhibited at the event:
· Biallelic Loss of Certain Genes in Adult Ph-Negative T-Acute Lymphoblastic Leukemia
· Primary Mediastinal B-Cell Lymphoma During Pregnancy
· Mutational Landscape of Tumor Cells in Patients With Chronic Myeloid Leukemia
· Incidence of Pseudoprogression During Nivolumab Plus R-DA-EPOCH Treatment for Primary Mediastinal B-Cell Lymphoma
· CAR T-Cell Therapy in Patients With Ultra-High-Risk Aggressive B-Cell Lymphoma (ABL) With TP53 Mutation
· Therapy of Aggressive B-Cell Lymphoma (ABL) With TP53 Gene Mutation
· OUTCOMES OF BCL2-R+ AND BCL2-R- FOLLICULAR LYMPHOMA TREATMENT
· Transformed and de novo variants of follicular lymphoma: analysis of patient survival based on modern therapy protocols
· Chemotherapy De-Escalation Does Not Alter the Effectiveness of Therapy for Ph + Acute Lymphocytic Leukemia in the Era of Tyrosine Kinase Inhibitors
